Development of a monkey model of Bordetella pertussis infection and disease
Development of a monkey model of Bordetella pertussis infection and disease
批准号:
7978754
负责人:
NICHOLAS H CARBONETTI
金额:
$26.25万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-15 至 2012-05-31
关键词:
AcuteAcute respiratory infectionAddressAgeAnimal ModelAnimalsBacteriaBindingBiological AssayBordetella pertussisBudgetsCharacteristicsChronicCoughingDevelopmentDiseaseExploratory/Developmental Grant for Diagnostic Cancer ImagingFeesFundingHousingHumanHuman VolunteersIndividualInfantInfectionInvestigationKnowledgeLeadLeukocytosisLungMacacaMacaca fascicularisModelingMolecularMonitorMonkeysMucous body substancePathogenesisPathologyPertussisPilot ProjectsPrimatesProductionReportingRespiratory FailureRespiratory SystemRespiratory Tract InfectionsRespiratory tract structureStructureStructure of respiratory epitheliumTestingTimeToxinVaccinesViolenceVirulence Factorscosteffective therapymeetingsnonhuman primatenovel therapeuticspathogenpreventpublic health relevanceresearch studysuccess
中文摘要
描述(由申请方提供):百日咳(百日咳)由细菌病原体百日咳博德特氏菌引起的呼吸道感染引起。这种疾病的最典型特征是持续数周甚至数月的阵发性(突然、剧烈、不受控制)咳嗽的衰弱发作。在幼儿中,百日咳可发展为致命的心肺功能衰竭,但百日咳咳嗽是一种在所有年龄段的个体中观察到的疾病。B。百日咳杆菌与呼吸道上皮细胞结合并在其上繁殖,释放出几种毒素,这些毒素被认为是导致疾病的原因。尽管对这种病原体的几种毒力因子的结构和功能有详细的分子认识,但我们对这种感染和疾病的发病机制的认识仍存在重大差距。特别是,我们对百日咳的病因及其特有的特征几乎一无所知。这主要是由于缺乏一个建立的动物模型,重现在人类中看到的感染和疾病。在20世纪20年代和30年代,对灵长类动物实验性百日咳感染的研究取得了不同的成功,但有足够的积极结果来保证新的现代研究。在本申请中,我们建议探索使用非人灵长类动物模型来研究百日咳感染和疾病的可行性。食蟹猴将用B进行肝内接种。百日咳和感染和疾病将随着时间的推移进行监测,包括评估引起的任何咳嗽。成功地建立这种模型将使我们能够解决这种发病机制的各个方面,特别是咳嗽,这是以前不适合实验研究,并将提供一个更相关的模型,人类百日咳感染和疾病。
公共卫生相关性:百日咳是近年来唯一呈上升趋势的疫苗可预防疾病,2005年美国报告的百日咳发病率达到50年来的最高水平。这种感染在婴儿中可能是致命的,并可能导致其他人虚弱和长期咳嗽,对他们没有有效的治疗方法。由于目前不允许进行百日咳的人类志愿者实验,猴子可能是再现人类感染和疾病的最佳动物模型,特别是长时间的严重咳嗽。该模型的成功建立将使我们能够研究百日咳咳嗽以及感染和疾病的许多其他方面,并可能导致开发新的治疗方法来预防或改善百日咳中的严重咳嗽。
英文摘要
DESCRIPTION (provided by applicant): Pertussis (whooping cough) is caused by respiratory infection with the bacterial pathogen Bordetella pertussis. The disease is characterized most typically by debilitating episodes of paroxysmal (sudden, violent, uncontrolled) coughing that persist for weeks or even months. In young infants, pertussis can progress to fatal cardio-respiratory failure, but pertussis cough is a disease observed in individuals of all ages. B. pertussis binds to and multiplies on the respiratory epithelium, releasing several toxins that are thought to contribute to the pathology. Despite a detailed molecular understanding of the structure and function of several virulence factors of this pathogen, there remain significant gaps in our knowledge of the pathogenesis of this infection and disease. In particular, we know next to nothing about the cause of pertussis cough and its peculiar characteristics. This is due primarily to the lack of an established animal model that reproduces the infection and disease seen in humans. Studies in the 1920s and 1930s on experimental pertussis infections in primates met with variable success, but there were sufficient positive results to warrant a new and modern investigation. In this application, we propose to explore the feasibility of using a non-human primate model to study pertussis infection and disease. Cynomolgus monkeys will be inoculated intratracheally with B. pertussis and infection and disease will be monitored over time, including assessment of any coughing elicited. Success in establishing this model would allow us to address aspects of this pathogenesis, particularly the cough, that have not previously been amenable to experimental study, and would provide a more relevant model of human pertussis infection and disease.
PUBLIC HEALTH RELEVANCE: Pertussis is the only vaccine-preventable disease that is on the rise in recent years, with 50-year highs reported in the US in 2005. The infection can be fatal in infants and can cause a debilitating and prolonged cough in other individuals, for whom there is no effective treatment. Since human volunteer experiments are not currently permissible for pertussis, monkeys potentially represent the best animal model that reproduces the infection and disease seen in humans, particularly the prolonged severe cough. Successful establishment of this model will allow us to study pertussis cough, as well as many other aspects of the infection and disease, and may lead to the development of novel therapeutics to prevent or ameliorate the severe cough in pertussis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems-Level Research in Microbial Pathogenesis
-
批准号:10671611
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2022
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of interferon lambda in protection against pertussis lethality in infants
-
批准号:10591086
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2022
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
IDO promotes severe manifestations of B. pertussis infection in infants
-
批准号:10286308
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2021
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
NK cell and interferon gamma deficiency in infant susceptibility to pertussis
-
批准号:10369616
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2021
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:10078317
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:10241992
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:10475402
-
项目类别:
-
资助金额:$6.09万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:9788241
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:10685140
-
项目类别:
-
资助金额:$6.01万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Age-dependent role of type I interferon in Bordetella pertussis pathogenesis
-
批准号:10462744
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2018
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Host-targeted therapeutics for pertussis in infants
-
批准号:9035033
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Sphingosine-1-phosphate signaling in pertussis pathogenesis and therapeutics
-
批准号:8953465
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2015
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Exacerbation of pertussis airway inflammation and pathology by pertussis toxin
-
批准号:8660610
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2013
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Exacerbation of pertussis airway inflammation and pathology by pertussis toxin
-
批准号:8577405
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2013
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Exacerbation of pertussis airway inflammation and pathology by pertussis toxin
-
批准号:8510801
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2012
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Development of a monkey model of Bordetella pertussis infection and disease
-
批准号:8088213
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2010
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
9th International Symposium on Bordetella
-
批准号:8007255
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2010
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Role of Pertussis Toxin in Bordetella pertussis infection
-
批准号:7151228
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2005
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Role of Pertussis Toxin in Bordetella pertussis infection
-
批准号:7799444
-
项目类别:
-
资助金额:$3.57万
-
财政年份:2005
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
Role of Pertussis Toxin in Bordetella pertussis infection
-
批准号:7319649
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2005
-
负责人:NICHOLAS H CARBONETTI
-
依托单位:
海外基金